DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
innovations during the drug
discovery phase.
FDA Denies Additional China-Developed Oncology Drugs
The U.S. Food and Drug Administration (FDA) declined approval for two additional ...
Building Effective Patient Retention Strategies Early in Study Design
“The Dropout: Building Effective Patient Retention Strategies Early in Study Design” by ...
Set Up for Success: Selecting Your CRO and Decentralized Vendors
“Set Your Trial Up for Success—Select Your CRO and Decentralized Vendors in Parallel” by ...
Scalable Considerations to Avoid Clinical Research Pitfalls
Clinical research would not be possible without the participation of patients who donate ...
Current State of Clinical Trials Impacted by the War in Ukraine
Current State of Clinical Trials Impacted by the War in Ukraine is Part One of a ...
Steps Organizations Can Take to Enable Better Patient Representation
“Health Inequities and the Path Ahead: Panel Shares Small Steps Organizations Can Take to ...
FDA Requires Randomized Data to Support PI3K Inhibitor Approvals
The Oncologic Drugs Advisory Committee (ODAC) convened a meeting on April 21, 2022, to ...
Designing Patient-Centric Decentralized Clinical Trials
“Best Practices For Designing Patient-Centric Decentralized Clinical Trials” by Jessica ...
Starting Social Media as a CMO: Strategic Considerations to Know
Not all Chief Medical Officers (CMOs) are public facing with marketing experience, and ...
Why It’s Never Too Early for Small Biotechs to Harness Clinical Data
Halloran’s webinar in partnership with CSL Behring on “Moving from Excel to Complete ...